Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospitals Cleveland Medical Center
With
Case Western Reserve University
Age
60–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects must have type I Bipolar disorder by DSM-IV criteria confirmed on the Mini Neuropsychiatric Interview (MINI)
Subjects must be age 60 or older
Subjects must have sub-optimal response to current psychotropic management including at least one of the following:
1. Behaviors and symptoms of irritability, agitation, mood lability or diminished ability to interact with others in their place of residence
2. Diminished ability to take care of basic personal needs in their place of residence due to symptoms of BD
You may not be if
History of intolerance or resistance to asenapine
Clinical diagnosis of dementia or Mini-mental state (MMSE) \< 24
History of TIA, stroke or MI within the past 12 months
Medical illness that is the clear, underlying etiology of BD
Unstable medical illness or condition including prolonged QT interval, which in the opinion of the study investigators, is likely to affect the outcome of the study or the subject's safety
DSM-IV substance dependence (except nicotine or caffeine) within the past 3 months.
Rapid cycling BD defined as 4 or more discrete mood episodes within the previous 12 months.
At high risk for self-harm or suicide
Clareo Health | Asenapine in the Treatment of Older Adults With Bipolar Disorder
